HIPOLIN LTD. (HIPOLIN) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of HIPOLIN LTD. ₹60.17, price ₹84.16, upside -28.5%, quality 64 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch HIPOLIN LTD. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range ₹17.70 – ₹219.70 · fair‑value band ₹45.57 – ₹79.72 · the ₹84.16 price screens above the ₹60.17 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow HIPOLIN in your weekly email
Every Wednesday you see whether HIPOLIN is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
HIPOLIN LTD. (HIPOLIN) currently trades at ₹84.16, while our model-based Fair Value estimate is ₹60.17, 28.5% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of ₹67.47 per share, and 0 of the 7 models we run sit above the ₹84.16 price.
Bear case: the Asset-Based group reads lowest at ₹15.82, and 7 of the 7 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹45.57 (bear) to ₹79.72 (bull), the price of ₹84.16 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 64/100 (solid quality), in the Consumer Staples sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
HIPOLIN LTD. reported revenue of ₹141M in FY2026 versus ₹122M in FY2022, a compound +3.7%/yr. Reported net income was −₹7.7M in FY2026.
Key figures
Market cap ₹264M (≈ $2.7M) · P/S ratio 1.56 · EPS (TTM) ₹−2.46 · Net margin −5.5% · Return on equity −9.9% · Return on assets (EBIT) −0.1% · Operating margin −0.1% · Revenue (TTM) ₹141M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 25% below its 52-week high and 80% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Staples peers we cover trades at 1% fair-value upside, at −29%, HIPOLIN screens richer than that median.
Fair Value models
Bear ₹45.57Fair Value ₹60.17Bull ₹79.72
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−34.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.9%
Start year 2021 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.3%
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−7.1% (2021) → −2.4% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+9.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +4.9% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Household Products” was too small, so the broader sector is used.)Consumer Staples · 1709 stocks
Beats the sector median on 3/9 measures
Overall it trails its sector peers.
Valuation
Quality Score64 · Top 25%
Fair Value upside−28.5% · Below median
Profitability
Return on assets−1.8% · Bottom 25%
Net margin (TTM)−5.5% · Bottom 25%
Operating margin (TTM)−0.1% · Bottom 25%
Growth and dividend
Revenue growth−10.5% · Bottom 25%
Balance sheet
Debt / equity0.10× · Above median
Valuation Multiplesvs Consumer Staples median · lower = cheaper
P/S (TTM)0.02× · Cheapest 25%
P/FCF0.2× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 32
FUTURE (revenue growth)0· sector 15
PAST (return on equity)0· sector 28
HEALTH (low debt)95· sector 95
DIVIDEND (yield)0· sector 56
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "HIPOLIN LTD. Fair Value". https://www.fairvalue-calculator.com/stock/HIPOLIN
Frequently asked questions
Is HIPOLIN LTD. (HIPOLIN) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹60.17 versus a price of ₹84.16, about −29% upside (overvalued).
What is the fair value of HIPOLIN?
Our model-based fair value for HIPOLIN LTD. is ₹60.17 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹84.16.
What is the quality score of HIPOLIN?
HIPOLIN LTD. has a Quality Score of 64/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for HIPOLIN LTD. (HIPOLIN)?
Our model-based price target is the fair value of ₹60.17 (as of Sep 27, 2026) from 7 valuation models. Cautious scenario ₹45.57, optimistic scenario ₹79.72. It is a calculation from audited fundamentals, not an analyst target.
What is the HIPOLIN LTD. stock forecast for 2026?
Our models put fair value at ₹60.17, about −29% upside versus a price of ₹84.16 (overvalued). Cautious scenario ₹45.57, optimistic scenario ₹79.72. The calculation is refreshed regularly with new filings.
What is the revenue of HIPOLIN LTD. (HIPOLIN)?
HIPOLIN LTD. reported trailing-twelve-month revenue of about ₹141M (latest available figure, as of Sep 27, 2026).
What growth is priced into HIPOLIN LTD. (HIPOLIN)?
For today's price to be fair in a discounted-cash-flow model, HIPOLIN LTD. would have to grow free cash flow by +9.2 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.9 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of HIPOLIN use?
Our models discount HIPOLIN LTD. at 10.9 %: a base by market capitalisation (nano), damped by beta 0.31, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For HIPOLIN LTD. that is +9.2 % per year a year over ten years, using the same discount rate (10.9 %) and the same formula as our fair value.
How much growth has HIPOLIN LTD. (HIPOLIN) delivered so far?
Over the past 5 years revenue at HIPOLIN LTD. grew +4.9 % a year. The price currently implies +9.2 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
What is the free cash flow yield of HIPOLIN LTD. (HIPOLIN)?
The free-cash-flow yield on the price is 6.12 %: that much free cash flow HIPOLIN LTD. produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of HIPOLIN LTD. (HIPOLIN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For HIPOLIN LTD. it is ₹60.17 per share (as of Sep 27, 2026), against a price of ₹84.16. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is HIPOLIN LTD. stock overvalued or undervalued in 2026?
As of Sep 27, 2026, HIPOLIN trades above its calculated fair value: price ₹84.16, fair value ₹60.17, a gap of about −29% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HIPOLIN?
No. The price is what the market pays today (₹84.16); the fair value is what the company's own numbers justify (₹60.17). For HIPOLIN LTD. the two are ₹23.99 per share apart. That gap is exactly why we show both numbers side by side.
How much is HIPOLIN LTD. worth?
The market values HIPOLIN LTD. at about ₹264M (market capitalisation, as of Sep 27, 2026). Per share that is ₹84.16; our models calculate a fair value of ₹60.17 per share.
What do the bullish and bearish scenarios say about HIPOLIN?
Our models span a range for HIPOLIN LTD.: cautious scenario ₹45.57, base ₹60.17, optimistic ₹79.72 per share (as of Sep 27, 2026, price ₹84.16). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of HIPOLIN LTD. (HIPOLIN)?
Balance-sheet figures for HIPOLIN LTD. (as of Sep 27, 2026): return on equity −9.9%, debt of 0.10 per unit of equity. They feed the Quality Score of 64/100, which measures business quality independently of the share price.
How far is HIPOLIN from its 52-week high?
HIPOLIN LTD. trades at ₹84.16, about 25% below its 52-week high of ₹111.90 and 80% above the low of ₹46.80 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹60.17 is for.
Which stocks are comparable to HIPOLIN LTD.?
From the same area (Consumer Staples) we also value CIANAGRO, SHINDL, SURJIND, Goodricke Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is HIPOLIN LTD. stock attractive at the current price?
The data as of Sep 27, 2026: price ₹84.16, calculated fair value ₹60.17 (−29%), Quality Score 64/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HIPOLIN calculated?
We run HIPOLIN LTD. through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹60.17, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. HIPOLIN LTD. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of HIPOLIN LTD. (HIPOLIN)?
The closing price on Oct 1, 2026 was ₹84.16. Our model-based fair value is ₹60.17, about −29% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with HIPOLIN LTD. right now?
The price sits above even our optimistic bull case (₹79.72). The favourable scenario is already priced in. Solid but not exceptional quality (64/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of HIPOLIN LTD.
How large is the market capitalisation of HIPOLIN LTD. (HIPOLIN)?
The market capitalisation of HIPOLIN LTD. is ₹264M (≈ $2.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of HIPOLIN LTD. (HIPOLIN)?
The price-to-sales ratio of HIPOLIN LTD. is 1.56 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of HIPOLIN LTD. (HIPOLIN)?
Earnings per share at HIPOLIN LTD. are ₹−2.46. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of HIPOLIN LTD. (HIPOLIN)?
The net margin of HIPOLIN LTD. is −5.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of HIPOLIN LTD. (HIPOLIN)?
The return on equity (ROE) of HIPOLIN LTD. is −9.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of HIPOLIN LTD. (HIPOLIN)?
On an EBIT basis the return on assets of HIPOLIN LTD. is −0.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of HIPOLIN LTD. (HIPOLIN)?
The operating margin of HIPOLIN LTD. is −0.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at HIPOLIN LTD. (HIPOLIN)?
Revenue at HIPOLIN LTD. is growing −10.5% versus a year earlier (3y avg −3.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does HIPOLIN LTD. (HIPOLIN) carry?
The net debt of HIPOLIN LTD. is ₹4.0M (fiscal year 2026, ≈ 0.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch HIPOLIN LTD. in the live analysis
One click puts HIPOLIN LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
